Rivastigmine Reduces “Likely to Use Methamphetamine” in Methamphetamine-Dependent Volunteers

Por De La Garza, R., Newton, T.F., Haile, C.N., Yoon, J.H., Nerumalla, C.S., Mahoney, J.J., Aziziyeh, A.
Publicado em 2011

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

Por Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Jurdi, R. K. Al, Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S., Newton, T. F., Mathew, S. J.
Publicado em 2013

Assessment of Safety, Cardiovascular and Subjective Effects After Intravenous Cocaine and Lofexidine

Por De La Garza, R., Galloway, G. P., Newton, T.F., Mendelson, J., Haile, C.N., Dib, E., Hawkins, R. Y., Chen, C-Y A., Mahoney, J.J., Mojsiak, J., Lao, G., Anderson, A., Kahn, R.
Publicado no Prog Neuropsychopharmacol Biol Psychiatry (2013)